{{Rsnum
|rsid=6922466
|Chromosome=6
|position=138123793
|Orientation=plus
|GMAF=0.1878
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|effect1=
|effect2=
|effect3=
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 52.7 | 41.1 | 6.2
| HCB | 71.3 | 27.9 | 0.7
| JPT | 66.4 | 31.0 | 2.7
| YRI | 81.6 | 15.6 | 2.7
| ASW | 66.7 | 29.8 | 3.5
| CHB | 71.3 | 27.9 | 0.7
| CHD | 74.3 | 24.8 | 0.9
| GIH | 30.7 | 53.5 | 15.8
| LWK | 70.9 | 25.5 | 3.6
| MEX | 72.4 | 22.4 | 5.2
| MKK | 62.8 | 28.2 | 9.0
| TSI | 53.9 | 40.2 | 5.9
| HapMapRevision=28
}}An association was found between [[systemic lupus erythematosus]] ([[SLE]]) and [[rs6922466]]. {{PMID|18677310}}

Three independent SNPs in the [[TNFAIP3]] region ([[rs13192841]], [[rs2230926]], and [[rs6922466]]) are associated with [[systemic lupus erythematosus]] ([[SLE]]) among individuals of European ancestry. {{PMID|19165919|OA=1
}}

{{omim
|desc=SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 13; SLEB13
|id=612378
|rsnum=6922466
}}

{{PMID Auto
|PMID=20049410
|Title=A functionally relevant IRF5 haplotype is associated with reduced risk of [[Wegener's granulomatosis]]
}}

{{PMID Auto
|PMID=20617138
|Title=Association of TNFAIP3 Polymorphism with Susceptibility to Systemic Lupus Erythematosus in a Japanese Population
|OA=1
}}

{{PMID|19169254|OA=1
}} Genome-wide scan reveals association of psoriasis with IL-23 and NF-kappaB pathways.

{{PMID|19387456|OA=1
}} Meta-analysis and imputation identifies a 109 kb risk haplotype spanning TNFAIP3 associated with lupus nephritis and hematologic manifestations.

{{PMID Auto
|PMID=22924496
|Title=Associations between TNFAIP3 gene polymorphisms and systemic lupus erythematosus: a meta-analysis.
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}